Elite Pharmaceuticals Market Cap

Elite Pharmaceuticals has a market cap or net worth of $429.68 million as of March 6, 2026. Its market cap has decreased by -15.64% in one year.

Market Cap

429.68M

Enterprise Value

414.64M

Revenue

140.12M

Ranking

n/a

PE Ratio

11.20

Stock Price

$0.40

Market Cap Chart

Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 429.68M, an increase of 4,387.43%. That is a compound annual growth rate of 14.76%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	430.76M	-18.22%
Dec 31, 2025	526.74M	-8.88%
Dec 31, 2024	578.04M	306.60%
Dec 29, 2023	142.16M	374.74%
Dec 30, 2022	29.95M	-10.40%
Dec 31, 2021	33.42M	-36.49%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Glass House Brands	718.57M
Nika Pharmaceuticals	791.42M
Jushi Holdings	105.50M
Growth Stalk Holdings	89.31M
Sofgen Pharma	55.75M
Radnostix	47.54M
Healthy Extracts	39.65M
MariMed	33.38M

Market Cap Rankings